Substance-Related Disorders
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
AlkermesDUBLIN 4, Ireland
2 programs1
1
naltrexone for extended release injectable suspensionPhase 41 trial
RDC-0313 + BuprenorphinePhase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Alkermesnaltrexone for extended release injectable suspension
AlkermesRDC-0313 + Buprenorphine
Clinical Trials (2)
Pre-Release VIVITROL for Opioid Dependent Inmates
Start: Mar 2012Est. completion: Aug 2015
Phase 4Completed
Phase 1 Study to Evaluate RDC-0313 Coadministered With Buprenorphine to Opioid-Experienced Healthy Adults
Start: Jan 2010Est. completion: Jul 2010
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space